J. Ignacio Diaz Email & Phone Number

Madrid, ES

Thailand

During the last 3 years we implemented three full portfolio (102 SKUs) evaluations in the SEA markets, including Thailand, Vietnam, Malaysia, Indonesia, Singapore, Philippines and Taiwan. We delivered a fully exhaustive evaluation of regulatory feasibility, commercial interest, pricing strategy, competition, plus a complete list of potential partners for.

Madrid, Spain / Ban Chang, Thailand

• Manage a team of 7 highly qualified professionals, plus 5 external local partners, in supporting the international expansion of more than 50 customers in APAC, Europe, Mena, and LATAM. Our experts work as an external.
• Manage a team of 7 highly qualified professionals, plus 5 external local partners, in supporting the international expansion of more than 50 customers in APAC, Europe, Mena, and LATAM. Our experts work as an external.
• Company founder and since 2015 GM with full P&L responsibility in Europe and Asia. Building the commercial/ administrative structure of the company, including selection, training, and leading a highly skilled team of.
• Full redefinition of the operational areas of the company by creating the #ophthalmic, #biosimilar, #medicaldevices, and #food supplements specialized divisions.
• Build an over 30.000 professional DB of connections belonging to more than 4.000 companies in the Healthcare segment worldwide, at senior levels (BD, GM, regulatory, R&D, commercial/ marketing), fully updated and.
• More than 150 projects developed in the international expansion of innovative products, medical devices, functional food, generics and biosimilars in Asia, Europe MENA and LATAM

Madrid Area, Spain

Developer of an innovative new methodology to select #biosimilarcandidates considering all the value chain, from #bio-API sourcing, manufacturing, registering, stakeholders, access to market, pricing expectations to company internal portfolio evaluation. Several lectures on biosimilar's commercial developmentStrategic partner of Pharma Synergy in the.

Bangkok Metropolitan Area

New platform committed to supporting business opportunities exchange within the biotech segment, with a special focus on biosimilars and bio-betters. We handle a more than 260 companies database covering pharmaceuticals developing, manufacturing, commercializing or interested in biosimilars worldwide.

Madrid

Launch of commercial activities in EU markets with the existing FDF portfolio in Oncology and Infectious Diseases Market entry in Denmark (winning first national tender attended), Spain (winning 4 first national tenders attended), UK (signed agreement with international partner generating first sales in the market), Germany (signing agreement with local.

Berlin Area, Germany

Consolidate Company Leadership in new geographies. New Services Design: Companies support for global expansion: access to European markets for companies developing products in Natural Health (food and drug). In/out licensing support for EU, US, APAC and LATAMCompany areas of expertise: Product design and development, regulatory strategy (EFSA, EMEA, FDA).

Madrid Area, Spain

M&A Activities in APAC, LATAM, AF.JV assessment activities in LATAM and APACActivities for opening Affiliates in: Thailand, Indonesia, Malaysia and The PhilippinesOut-licencing activities in GI, GYN, PED, Res, Derma Rx products to US and APACIn-licencing activities with priority in GI, GYN, PED, RES, DIABResponsible for commercial evaluation of Internal.

Paris Area, France

Marketing plans and sales objectives supervision and approval for 61 countries in two strategic therapeutic areas (Diabetes and Bone Metabolism) Team member on Diabetes Market Access ProgramMember of the Global Market Team in Bone MetabolismTeam leader of Amaryl M project, a multitask team created to launch combination of Glimepiride and Metformine in 52.

Barcelona Area, Spain

Design and development of the Linea Clasica concept for Mature Portfolio Management (120 million euros). Linea Clasica was a project based on the selection of products suitable for active promotion and after the approval of a business case including external sales force activities and pilot test results, implement a highly innovative and profitable direct.

Barcelona Area, Spain

Marketing responsible for Aprovel, antihipertensive blockbuster ranked 2nd in company sales 2.003. Aprovel is a ARB II with significant effect lowering blood pressure and renal protection. Core activities were Marketing Plan design and implementation, KOL management with Cardiogists, Internal Medicine and Primary Care Physicians and Sales Force.

Madrid Area, Spain

Pharma Division start-up and development

Madrid Area, Spain

Responsible of successful launching of four HIV products in Spain, including the first protease inhibitors

Madrid

Distribution change from Exclusive Distributors to 86 Direct Sales Force. Team training and bonus scheme development

Bachelor Of Engineering (Beng), Geology And Geophysics, Superior Mining Engeneer

Bachelor Of Business Administration (Bba), Business Administration And Management, General